Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show

InnoCare to Present at the Morgan Stanley 2020 Virtual Asia Pacific Conference & ZGC Forum


InnoCare Pharmaceuticals (HKEX: 09969), a clinical stage biopharmaceutical company committed to discovering, developing, and commercializing innovative medicines for the treatment of cancer and autoimmune diseases, announced today that the company will present at the upcoming Morgan Stanley 2020 Virtual Asia Pacific Conference and ZGC Forum.

InnoCare CFO, Mr. Shaojing Tong, will join the China Biotech Panel of the Morgan Stanley conference to discuss and share the insights of China's booming biotech industry on Thursday, September 24, 2020 China time.

Meanwhile, InnoCare will exhibit innovative medicine at the ZGC forum from September 17-20 in Beijing. Dr. Renbin Zhao, Executive Director of Biology and Clinical Development Strategy of InnoCare will present on the latest development of BTK inhibitor Orelabrutinib on the afternoon of Thursday, September 17, 2020, China time.

Founded in 2007, the ZGC forum has been held for years with the mission to promote communication, exchange, and cooperation in the field of science and technology worldwide.

About InnoCare Pharma

InnoCare Pharmaceuticals is a clinical stage biopharmaceutical company committed to discovering, developing, and commercializing first-in-class and/or best-in-class drugs for the treatment of cancer and autoimmune diseases. We strategically focus on lymphoma, solid tumors, and autoimmune disease with high unmet medical needs in China and worldwide. InnoCare has branches in Beijing, Nanjing, Shanghai, Guangzhou, New Jersey, and Boston.


These press releases may also interest you

at 08:15
Seagen Inc. today announced the closing of a $1.0 billion equity investment by Merck in 5.0 million newly-issued shares of Seagen common stock at a price of $200 per share. The closing occurred following expiration of the waiting period under the...

at 08:15
Abiomed announces the first two patients have been treated with the Impella ECP expandable percutaneous heart pump. Impella ECP is the smallest heart pump in the world. It measures 9 French (Fr) (3 millimeters) in diameter upon insertion and removal...

at 08:15
NeuroEM Therapeutics is poised to deliver a knockout blow to Alzheimer's disease. The clinical-stage medical device company is pleased to announce FDA Breakthrough Device designation for its bioengineered head device shown to reverse Alzheimer's...

at 08:14
Neuroverse®, Inc. is proud to partner with National Geographic and Jeff Goldblum to promote positive mental health as part of the worldwide release of the Disney+, Emmy Award nominated series, "The World According to Jeff Goldblum"....

at 08:14
PayPal Holdings, Inc. today announced it will invest $50 million in eight early-stage, Black and Latinx-led venture capital funds: Chingona Ventures; Fearless Fund; Harlem Capital; Precursor Ventures; Slauson & Co.; VamosVentures; Zeal Capital...

at 08:13
STORA ENSO OYJ INVESTOR NEWS 28 October 2020 at 14.00 EET Stora Enso will arrange a virtual Capital Markets Day 2020 for investors and analysts on 11 November 2020. The event will start at 14.00 EET (13.00 CET, 12.00 UK time & 07.00 EST) and end at...



News published on 17 september 2020 at 04:55 and distributed by: